Solutions for BioVeris™ owners


Gyrolab is a future-proof solution that offers a smooth technology transition, a robust workflow and unique advantages

BioVeris assays in 2009?

With questions being raised about how long Roche intends to support the BioVeris product line, users need to decide how to resolve their current workflow and long-term projects. While switching to MSD may seem like a logical option due to technology compatibility, it doesn’t necessarily provide the best long-term solution. It is a question of selecting the right partner and technology to match future requirements. Spending time to address tricky issues during assay optimization and multiplex assays counteracts efforts to improve workflow efficiency and overall throughput. Gyrolab represents a future-proof, simple to use and effective solution that can take BioVeris users to a new level of efficiency and productivity.

The perfect time to partner with Gyros

Gyros technology has established itself within many application areas, delivering high quality, trustworthy results, along with inherent advantages over traditional technologies. Its unique advantages are supported by first-class services, including GxP qualification support and application support. Gyros has a global perspective and also helps to address many of the current ethical considerations. Put simply, Gyros allows the biopharmaceutical industry to do more using less time and resources.

Flexible and future-proof platform

Gyrolab is a flexible, bioanalytical system that significantly increases effectiveness, and addresses critical needs, within the development of protein therapeutics, all the way from process development to the completion of clinical trials. What’s more, Gyros is in control of all its own patents which ensures that your investment is future-proof.

The fastest way to new assay development

Gyrolab offers a fast track to new assay development – and is the fastest way of knowing whether an assay will work or not. The open, flexible system and unique assay development visualization tools mean that new assays can be developed and optimized within days. The system facilitates quantification of any target protein for which an immunoassay can be developed.

High quality, reliable results

Gyrolab is a robust system that generates highly trustworthy and reliable results, with a high degree of recovery, reproducibility and sensitivity. The flow-through format also means that matrix effects are reduced allowing accurate analysis of complex samples.

Simple to use with unattended operation

A high degree of in-built automation ensures a robust workflow. Gyrolab is a simple to use, ‘hands-off’ solution that allows hours of unattended operation. Unlike some other technologies, it is not operator dependent, which greatly improves assay transferability.

Take a look around the website and find out for yourself how Gyrolab could support your vision of a successful future.

For Gyros AB

Katie Odgaard / Lorna Cuddon
Zyme Communications Ltd
Tel: +44 (0) 7787 502 947 / +44 (0) 7811 996 942
Skype: kodgaard / lorna.cuddon
Email: /

Notes to editors:
About Gyros (

Gyros AB is the world leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The GyrosTM immunoassay platform increases productivity and efficiency during development of biotherapeutics and vaccines, saving time and labor. Major biopharmaceutical companies and their service providers utilize the Gyros platform to boost time-critical workflows and meet increasing regulatory demands.

Spanning the entire spectrum of immunoassays, the platform cuts the time to result significantly. Faster development times, and unattended running of assays at nano-liter scale, save labor and sample. The ease of assay transfer between sites and from development to regulated environments is unsurpassed in the industry.

The company is based in Uppsala, Sweden and has regional sales and support offices in the USA and Europe, and a growing network of distributors.